IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 214 filers reported holding IMMUNOGEN INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $77,000 | +24.2% | 10,713 | +1.6% | 0.00% | – |
Q4 2020 | $62,000 | +100.0% | 10,548 | -8.2% | 0.00% | – |
Q3 2020 | $31,000 | -93.6% | 11,493 | -89.3% | 0.00% | -100.0% |
Q2 2020 | $485,000 | +2594.4% | 107,646 | +298.3% | 0.00% | – |
Q3 2019 | $18,000 | -21.7% | 27,027 | +11.5% | 0.00% | – |
Q2 2019 | $23,000 | -37.8% | 24,238 | +135.6% | 0.00% | – |
Q4 2018 | $37,000 | -64.4% | 10,288 | -5.2% | 0.00% | -100.0% |
Q2 2018 | $104,000 | -12.6% | 10,857 | -4.2% | 0.00% | 0.0% |
Q1 2018 | $119,000 | +60.8% | 11,334 | -6.3% | 0.00% | 0.0% |
Q4 2017 | $74,000 | -28.2% | 12,097 | -8.5% | 0.00% | 0.0% |
Q3 2017 | $103,000 | -19.5% | 13,220 | -23.1% | 0.00% | 0.0% |
Q2 2017 | $128,000 | +93.9% | 17,184 | -0.1% | 0.00% | 0.0% |
Q1 2017 | $66,000 | +288.2% | 17,202 | +23.6% | 0.00% | – |
Q4 2016 | $17,000 | -62.2% | 13,913 | -28.5% | 0.00% | -100.0% |
Q3 2016 | $45,000 | -70.0% | 19,461 | +12.6% | 0.00% | – |
Q1 2016 | $150,000 | -38.0% | 17,284 | -4.7% | 0.00% | -100.0% |
Q4 2015 | $242,000 | – | 18,144 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 10,477,879 | $37,720,000 | 0.69% |
QVT Financial LP | 1,375,900 | $4,953,000 | 0.60% |
RA Capital Management | 7,040,485 | $25,346,000 | 0.46% |
Birchview Capital, LP | 380,000 | $1,368,000 | 0.46% |
XTX MARKETS LLC | 18,861 | $68,000 | 0.33% |
Fernwood Investment Management, LLC | 154,340 | $556,000 | 0.26% |
TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $375,000 | 0.14% |
Virtus ETF Advisers LLC | 70,213 | $253,000 | 0.13% |
KENNEDY CAPITAL MANAGEMENT LLC | 1,251,458 | $4,505,000 | 0.13% |
Assenagon Asset Management S.A. | 4,987,334 | $17,954,000 | 0.10% |